| Literature DB >> 35509290 |
Eric S Dilbone1, Stephanie N Moore-Lotridge1,2, Michael Gabbard1, Jacob D Schultz3, Andrew B Rees3, J Ryan Martin1, Gregory G Polkowski1.
Abstract
Background: Prosthetic hip dislocation remains one of the most frequent complications following total hip replacement. Dislocations are predominantly managed by a closed reduction in the emergency department (ED) or the operating room (OR). This study aimed to evaluate how the location of an initial closed reduction attempt impacts a patient's course of care including length of stay (LOS) and cost of care. Material and methods: A retrospective chart review was performed on all patients presenting to a single ED with a unilateral prosthetic hip dislocation from 2009 to 2019. A total of 108 patients were identified. Data collected included patient demographics, ED/hospital course, and hospital charges.Entities:
Keywords: Cost; Cost of care; Dislocation; Instability; Prosthetic complication; THA
Year: 2022 PMID: 35509290 PMCID: PMC9058571 DOI: 10.1016/j.artd.2022.03.002
Source DB: PubMed Journal: Arthroplast Today ISSN: 2352-3441
Figure 1Flow chart with breakdown of patients with associated exclusion criteria.
Reasons cited for needing OR reduction/unwilling to attempt in ED.
| Reason for no sedation | No ED reduction attempted (direct to OR) (N = 34) |
|---|---|
| ASA Class > II | 27 (79.4) |
| Difficult airway | 1 (2.9) |
| History of requiring a prior OR reduction | 2 (5.9) |
| Other | 10 (29.4) |
Included concomitant pelvic fractures, hypotension/vital sign instability, chronic obstructive pulmonary disease, suspected need for open reduction, history of pulseless electrical activity arrest from OR or prior sedation, heart transplant patient, or extensive/complex cardiac history or other active medical comorbidity.
Patient demographics.
| Demographic category | Total population (N = 108) | ED reduction attempted (N = 74) | No ED reduction attempted (direct to OR) (N = 34) | |
|---|---|---|---|---|
| Age, median (range) | 61.8 (29.0-92.0) | 60.7 (29.0-90.1) | 71.4 (50.3-92.0) | .001 |
| Male, N (%) | 60 (55.6) | 44 (59.5) | 16 (47.1) | .228 |
| BMI, median (range) | 26.8 (17.9-64.1) | 26.8 (18.0-43.8) | 26.7 (17.9-64.1) | .668 |
| ASA Class, N (%) | <.001 | |||
| I | 8 (7.4) | 8 (10.8) | 0 (0.0) | |
| II | 22 (20.4) | 22 (29.7) | 0 (0.0) | |
| III | 52 (48.1) | 30 (40.5) | 22 (64.7) | |
| IV | 11 (10.2) | 1 (1.4) | 10 (29.4) | |
| V | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Not specified | 15 (13.9) | 13 (17.6) | 2 (5.9) | |
| Comorbidities, N (%) | ||||
| Cardiovascular | 46 (42.6) | 26 (35.1) | 20 (58.8) | .021 |
| Pulmonary | 36 (33.3) | 18 (24.3) | 18 (52.9) | .005 |
| Diabetes | ||||
| No disease | 82 (73.2) | 57 (77.0) | 25 (73.5) | .596 |
| Diet controlled | 10 (8.9) | 5 (6.8) | 5 (14.7) | |
| Oral medication | 7 (6.3) | 5 (6.8) | 2 (5.9) | |
| Insulin dependent | 9 (8.0) | 7 (9.5) | 2 (5.9) |
Cardiovascular comorbidities include myocardial infarction, prior placement of a stent, congestive heart failure, coronary artery disease, or arrhythmia (with or without anticoagulation).
Pulmonary comorbidities include chronic obstructive pulmonary disease, home O2 use, history of asthma, prior history of pulmonary embolism, sleep apnea, pulmonary hypertension, and other chronic pulmonary conditions.
Figure 2(a) Scatterplot showing time to reduction for all 3 cohorts (minutes). (b) Scatterplot showing length of stay (days). (c) Scatterplot showing cost of care for all 3 cohorts ($US).
Patient disposition from hospital.
| Location of patient disposition | Total population (N = 112) | ED reduction successful (N = 65) | ED reduction failed (N = 9) | No ED reduction attempted (direct to OR) (N = 34) | |
|---|---|---|---|---|---|
| Discharged to home, N (%) | 91 (81.2) | 60 (92.3) | 6 (66.7) | 24 (70.6) | .007 |
| Discharged to SNF, N (%) | 19 (17.0) | 4 (6.2) | 3 (33.3) | 9 (26.5) | |
| Died during hospitalization, N (%) | 1 (0.9) | 0 (0) | 0 (0) | 1 (2.9) | |
| Left hospital against medical advice, N (%) | 1 (0.9) | 1 (1.5) | 0 (0) | 0 (0) |
SNF, skilled nursing facility.